Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Nishizawa

Showing results (31-40 of 159) with videos related to

Pageof 16
Sort By:
Diabetology & Metabolic Syndrome|September 20, 2014
Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational studyKana Inoue, Norikazu Maeda, Yuya Fujishima, et al.
Endocrine Journal|October 7, 2014
The prevalence of acromegaly in hospitalized patients with type 2 diabetesKentaro Suda, Hidenori Fukuoka, Genzo Iguchi, et al.
Pituitary|July 1, 2015
The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoLKenichi Yoshida, Hidenori Fukuoka, Ryusaku Matsumoto, et al.
Endocrine Journal|April 7, 2022
Genetic assessment using whole-exome sequencing for a young hypertriglyceridemic patient with repeated acute pancreatitisShingo Fujita, Hitoshi Nishizawa, Yohei Miyashita, et al.
Frontiers in Endocrinology|April 17, 2023
Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trialMayumi Hirosaki, Tetsuya Ohira, Yawei Wu, et al.
Endocrine Journal|May 12, 2024
Association between COVID-19 severity and relatively high serum adiponectin levels at the time of admissionRyohei Mineo, Shiro Fukuda, Shigehito Suzuki, et al.
Journal of Cardiology|August 10, 2011
Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failureTakahiro Ohara, Kazuhiko Hashimura, Masanori Asakura, et al.
Journal of Atherosclerosis and Thrombosis|March 6, 2023
Effect of a Community-Based Program to Accelerate Referral to Physicians for Individuals at High-Risk of Lifestyle-Related Diseases: A Cluster Randomized TrialHiroyasu Iso, Midori Noguchi, Tetsuji Yokoyama, et al.
European Journal of Endocrinology|October 30, 2013
The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literatureHironori Bando, Genzo Iguchi, Hidenori Fukuoka, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 27, 2010
IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytesHidenori Fukuoka, Keiji Iida, Hitoshi Nishizawa, et al.
Pageof 16

Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
Diabetology & Metabolic Syndrome|September 20, 2014
Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational studyKana Inoue, Norikazu Maeda, Yuya Fujishima, et al.
Endocrine Journal|October 7, 2014
The prevalence of acromegaly in hospitalized patients with type 2 diabetesKentaro Suda, Hidenori Fukuoka, Genzo Iguchi, et al.
Pituitary|July 1, 2015
The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoLKenichi Yoshida, Hidenori Fukuoka, Ryusaku Matsumoto, et al.
Endocrine Journal|April 7, 2022
Genetic assessment using whole-exome sequencing for a young hypertriglyceridemic patient with repeated acute pancreatitisShingo Fujita, Hitoshi Nishizawa, Yohei Miyashita, et al.
Frontiers in Endocrinology|April 17, 2023
Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trialMayumi Hirosaki, Tetsuya Ohira, Yawei Wu, et al.
Endocrine Journal|May 12, 2024
Association between COVID-19 severity and relatively high serum adiponectin levels at the time of admissionRyohei Mineo, Shiro Fukuda, Shigehito Suzuki, et al.
Journal of Cardiology|August 10, 2011
Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failureTakahiro Ohara, Kazuhiko Hashimura, Masanori Asakura, et al.
Journal of Atherosclerosis and Thrombosis|March 6, 2023
Effect of a Community-Based Program to Accelerate Referral to Physicians for Individuals at High-Risk of Lifestyle-Related Diseases: A Cluster Randomized TrialHiroyasu Iso, Midori Noguchi, Tetsuji Yokoyama, et al.
European Journal of Endocrinology|October 30, 2013
The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literatureHironori Bando, Genzo Iguchi, Hidenori Fukuoka, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 27, 2010
IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytesHidenori Fukuoka, Keiji Iida, Hitoshi Nishizawa, et al.
Pageof 16